首页> 外文会议>International Conference on Bioinformatics and Systems Biology >In-silico mining of SNP-effects on structural properties of CYP2C9 and their consequences
【24h】

In-silico mining of SNP-effects on structural properties of CYP2C9 and their consequences

机译:在计算机上开采SNP对CYP2C9结构性质的影响及其后果

获取原文

摘要

CYP2C9 is one of the important members of CYP450 family, which is well known to play very important and crucial role in drug and toxic compounds metabolism. CYP2C9 alone is responsible for the metabolism of more than 20% drugs. Today list of drugs are known as drug designed to be metabolized by CYP2C9. It has been observed that presence of population specific, non-synonymous SNPs in CYP2C9 alter the rate of drug metabolism and as a consequence, drug produce abnormal response, i.e.-variable drug response, in individuals belongs to different population group. In current work by using CYP2C9*2 (mutant1 144Arg>Cys) and CYP2C9*3 (mutant2 359Ile>Leu) SNP-variant of CYP2C9 we try to elucidated the alterations in physiochemical and structural properties in compare with the properties of wild type CYP2C9. Further we also try to observe the effect of altered features on molecular folding and interaction through MD simulation, and docking between CYP2C9 and its two variants (CYP2C9*2 and CYP2C9*3) with warfarin, which is a one of well-known anticoagulant and metabolized by CYP2C9.
机译:CYP2C9是CYP450家族的重要成员之一,众所周知,它在药物和有毒化合物的代谢中起着非常重要和至关重要的作用。仅CYP2C9负责20%以上药物的代谢。今天的药物清单被称为旨在通过CYP2C9代谢的药物。已经观察到,CYP2C9中群体特异性,非同义SNP的存在改变了药物代谢的速率,结果,在属于不同人群的个体中,药物产生异常反应,即可变药物反应。在当前的工作中,通过使用CYP2C9的CYP2C9 * 2(mutant1 144Arg> Cys)和CYP2C9 * 3(mutant2 359Ile> Leu)SNP-变体,我们试图阐明与野生型CYP2C9的性质相比,理化性质和结构性质的变化。此外,我们还尝试通过MD模拟观察改变的特征对分子折叠和相互作用的影响,以及将CYP2C9及其两个变体(CYP2C9 * 2和CYP2C9 * 3)与华法林对接,华法林是一种著名的抗凝血剂,通过CYP2C9代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号